Biography

Yun Cui, M.D., Ph.D. I have long been engaged in biopsy and postoperative pathological diagnosis of digestive tract tumors and non-neoplastic diseases. Good at endoscopy combined with pathology in the diagnosis of early gastrointestinal cancer. I am familiar with the endoscopic and pathological diagnosis system of early gastrointestinal cancer in China and abroad, and have rich clinical experience in pathological diagnosis and precise treatment of early gastrointestinal cancer. The carcinogenesis pathway, precancerous lesions, risk factors and pathogenesis of early gastrointestinal cancer were studied in depth. I have hosted a National Natural Science Foundation project and published several papers in international journals. At the same time, I have accumulated a lot of practical experience in the pathological diagnosis and differential diagnosis of inflammatory bowel disease. I have described the biopsy mucosal characteristics of Crohn's disease in detail in international journals. In addition, I have been engaged in the teaching of digestive pathology and the guidance of postgraduate students for a long time. I keep track of the research progress and diagnostic consensus in related fields, and provide the latest knowledge system for students. I am a good mentor and helpful friend to students.

Educational experience (starting with undergraduate degree, in reverse chronological order)

• 2008/9-2011/6, Department of Clinical Medicine, School of Medicine, Shanghai Jiao Tong University, Ph.D

• 2002/9-2005/6, Department of Clinical Medicine, Fourth Military Medical University, Master

• 1997/9-2002/6, Department of Clinical Medicine, Xinxiang Medical College, Bachelor

Research and Work experience (in reverse chronological order)

• 2020/12-present: Department of Gastroenterology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Associate chief physician,

• 2012/12-2020/11, Department of Gastroenterology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Attending physician

• 2011/12-2012/11, Department of Pathology, Boston Health System VA Hospital, Harvard University School of Medicine, USA, Visiting Scholar

• 2005/9－2011/11, Department of Gastroenterology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Resident physician,

Representative papers

• Yun Qian, Wei He, Chu Yi Zheng, Jin Hui Xue, Jing Yuan Fang, Xiao Yu Chen, Yun Cui. Significance of granuloma and granulomatous lymphangitis in the differential diagnosis of Crohn's disease. J Dig Dis. 2020;21(8):454-461.

• Yun Cui, Shi-yuan Lu, Jie Xu, Yan-shen Peng，Qi Miao, Xiao-qing Wang, Xiao-yu Chen, Zhi-hua Ran. Microscopic features of small bowel mucosa of patients with Crohn’s disease. BMC Gastroenterol. 2019;19(1):232.

• 崔云 ,陆诗媛 ,陈萦晅 ,陈晓宇 ,房静远. 慢性胃炎的病理诊断.《临床荟萃》 2019；(34)5:399-402

• Qing Yan FU, Yun CUI, Xiao Bo LI, Ping CHEN, Xiao Yu CHEN. Relevant risk factors for positive lateral margin after en bloc endoscopic submucosal dissection for early gastric adenocarcinoma.J Dig Dis. 2016;17(4):244-251.

• Ping Chen, Yun Cui, Qing Yan Fu, You Yong LU, Jing Yuan FANG, Xiao Yu CHEN. Positive relationship between p42.3 gene and inflammation in chronic non-atrophic gastritis. J Dig Dis. 2015;16(10):568-574.

• Cui Y, Su WY, Xing J, Wang YC, Wang P, Chen XY, Shen ZY, Cao H, Lu YY, Fang JY. MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer. PLoS One. 2011；6(10):e25872.

• Cui Y, Xue H, Lin B, Ni P, Fang JY. A meta-analysis of CDH1 C-160A genetic polymorphism and gastric cancer risk. DNA Cell Biol. 2011；30(11):937-945.